Home / Meetings and Events


CASSS meetings bring together industry, regulatory and academic professionals for critical discussions to solve technical and regulatory challenges in the field of biopharmaceutical development. CASSS symposia and fora provide venues for biopharmaceutical professionals to: 

  • Connect with a relevant global network
  • Gain tangible knowledge for career advancement
  • Learn best practices from prominent contributors in the industry

  • 'CASSS Couch Chats' Couch Chats
    March 28, 2024

    The Couch Chats will build our community and foster meaningful connections while collaborating to address real-time biopharmaceutical problems.

  • Image of orange background with text 'CASSS Discussion Groups' DC Discussion Group
    April 3, 2024

    Join us in person at the IBBR campus where you can network with DC-area CASSS members.

  • Image with text 'bioassays scientific approaches and regulatory strategies' Bioassays
    April 15 to 17, 2024

    Bioassays presents an opportunity to interact with key industry thought leaders and discuss topics such as current perspectives, strategies, and technologies used for bioassays.

  • Image with text 'CASSS Consultants' Network' Consultants' Network
    April 15, 2024

    The purpose of the CASSS Consultants' Network is to facilitate discussions among consultants.

  • Image of DNA helix with text 'CGTP Summit' CGTP Summit
    June 10, 2024

    The Summit is designed to discuss pertinent challenges in the cell and gene therapy field. This one-day program will include speaker presentations with interactive, in-depth panel discussions.

  • Image of DNA helix with text 'Cell & Gene Therapy Products Manufacturing, Quality and Regulatory Considerations' Cell and Gene Therapy Products
    June 11 to 13, 2024

    The Symposium will bring together industry, regulatory, and academic professionals to discuss pertinent challenges in the cell and gene therapy field.

  • Image with hexagons and text 'CMC Strategy Forum North America Advancing Biopharmaceutical Development' CMC Strategy Forum North America
    July 16 to 17, 2024

    The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product.

  • Image of bright green background with hexagons and text 'Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry' Mass Spectrometry
    September 10 to 13, 2024

    The focus of this Symposium is the practical application of mass spectrometry (MS) in the biotechnology industry.

  • Image of turquoise with text 'HOS Because Structure Matters' Higher Order Structure
    September 11 to 13, 2024

    For protein-based therapeutic products, HOS is a critical quality attribute which needs to be monitored to ensure safety and efficacy of drug products.

  • Image with text 'CE in the Biotechnology & Pharmaceutical Industries' CE Pharm
    September 15 to 18, 2024

    The Symposium provides a forum for the discussion of recent developments in capillary electrophoresis (CE) analysis of protein, nucleotide, and small molecule pharmaceuticals.

  • Image of dark blue background with text 'CMC Strategy Forum Europe' CMC Strategy Forum Europe
    October 21 to 23, 2024

    The Forum will follow the established model of the CMC Forum series with a focus on topics and regulatory updates relevant to Europe.

  • Image with text 'cmc strategy forum japan advancing biopharmaceutical development' CMC Strategy Forum Japan
    December 9 to 10, 2024

    The Forum will follow the established model of the CMC Forum series with a focus on topics and regulatory updates relevant to Japan and Asia Pacific.

  • Image of purple background with text 'WCBP' WCBP
    January 28 to 30, 2025

    The WCBP Symposium addresses the role of current and emerging CMC analytical technology among evolving US and international regulatory perspectives.

Fast Facts

  • Annually, CASSS holds 13 scientific, multi-day symposia and fora around the world.
  • Attendees represent more than 30 regulatory agencies and over 100 biopharmaceutical companies from Africa, Asia, Australia, Canada, Europe, Latin America, Middle East, and United States.

Code of Conduct

CASSS is committed to providing a safe, productive, and welcoming environment for all meeting participants and CASSS staff. All participants, including, but not limited to, attendees, speakers, volunteers, industry, partners, exhibitors, CASSS staff members, service providers, and all others are expected to abide by this Code of Conduct.

View Code of Conduct